ENGNW
Financials
- Market Capitalization 124.6004 M
- Employee 82
- Founded N/A
- CEO N/A
- Website www.engene.com
- Headquarter Canada (Federal Level)
- FIGI BBG01J1GCYW7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7273 |  HUMAW Humacyte, Inc. - Warrant | 0.0076 USD | 0.00% | -23.23% | -67.80% | -98.42% | 155.41 M USD | ||
| 7274 |  YDESW YD Bio Limited - Warrants | 0.2561 USD | 0.00% | -22.44% | -21.22% | -53.44% | 152.20 M USD | ||
| 7292 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.70 USD | 0.00% | -6.78% | -10.53% | +124.22% | 125.70 M USD | ||
| 7363 |  CINGW Cingulate Inc. - Warrants | 0.0233 USD | 0.00% | +17.68% | +16.50% | -45.18% | 62.13 M USD |
Frequently asked questions about enGene Therapeutics Inc. - Warrants
What is the enGene Therapeutics Inc. - Warrants stock price today?
The current price of enGene Therapeutics Inc. - Warrants (ENGNW) is 0.32. Over the past 24 hours, the stock has changed by +0.03%. Follow the ENGNW chart for real-time price dynamics.
What is the stock ticker of enGene Therapeutics Inc. - Warrants?
enGene Therapeutics Inc. - Warrants trades under the ticker ENGNW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is enGene Therapeutics Inc. - Warrants stock going up?
ENGNW has changed by +10.34% over the last week, +38.17% over the last month, and -60.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does enGene Therapeutics Inc. - Warrants release financial reports?
Yes. You can track enGene Therapeutics Inc. - Warrants financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was enGene Therapeutics Inc. - Warrants net income for the last quarter?
enGene Therapeutics Inc. - Warrants reported net income of -30.23 M for the last quarter. The previous quarter showed -29.75 M, which means net income changed by -1.60%.
How many employees does enGene Therapeutics Inc. - Warrants have?
As of the latest available data, enGene Therapeutics Inc. - Warrants has 82 employees. Workforce size can provide additional context about the company's scale and operations.
What is enGene Therapeutics Inc. - Warrants EBITDA?
enGene Therapeutics Inc. - Warrants EBITDA is -31.74 M, and its EBITDA margin is -109.44 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy enGene Therapeutics Inc. - Warrants stock?
You can buy enGene Therapeutics Inc. - Warrants (ENGNW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in enGene Therapeutics Inc. - Warrants stock?
Investing in enGene Therapeutics Inc. - Warrants requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENGNW chart and related analysis on metatrader.com as part of your research.